A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
NCT07538466 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-04-20
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Conditions
Interventions
- DRUG
-
AD-123
AD-123 Oral Tablet
- DRUG
-
AD-1231 and AD-1232
AD-1231 Oral Tablet + AD-1232 Oral Tablet
Sponsors & Collaborators
-
Addpharma Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
NCT01796366 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes
NCT02030600 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes
NCT00604396 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
NCT02536859 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
NCT02612844 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®
NCT06492226 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
NCT00715780 ·Status: COMPLETED
-
Safety of NNC 0123-0000-0338 in Healthy Subjects
NCT01334034 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
NCT00184613 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects
NCT01868555 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects
NCT01967589 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects
NCT05576298 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
NCT01324505 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
NCT02607306 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration
NCT01908894 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
NCT02146651 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
NCT02213146 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
NCT07305805 ·Status: RECRUITING ·Phase: PHASE1
-
A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes
NCT05373212 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects
NCT02479022 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
NCT01269606 ·Status: COMPLETED ·Phase: PHASE1
-
Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects
NCT01405261 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension
NCT00790153 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus
NCT01364428 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone
NCT00604253 ·Status: COMPLETED ·Phase: PHASE3